127 related articles for article (PubMed ID: 21045192)
1. Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?
Crow AR; Song S; Suppa SJ; Ma S; Reilly MP; Andre P; McKenzie SE; Lazarus AH
Blood; 2011 Jan; 117(3):971-4. PubMed ID: 21045192
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.
Crow AR; Yu H; Han D; Lazarus AH
PLoS One; 2013; 8(8):e71882. PubMed ID: 23940791
[TBL] [Abstract][Full Text] [Related]
3. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
Crow AR; Amash A; Lazarus AH
Transfusion; 2015 Jun; 55(6 Pt 2):1492-500. PubMed ID: 25496771
[TBL] [Abstract][Full Text] [Related]
4. The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.
Crow AR; Suppa SJ; Chen X; Mott PJ; Lazarus AH
Blood; 2011 Dec; 118(24):6403-6. PubMed ID: 22001393
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
Song S; Crow AR; Freedman J; Lazarus AH
Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition.
Norris PAA; Kaur G; Khan R; Zhu G; Ni H; Lazarus AH
Blood; 2021 Apr; 137(15):2114-2124. PubMed ID: 33662988
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.
Song S; Crow AR; Siragam V; Freedman J; Lazarus AH
Blood; 2005 Feb; 105(4):1546-8. PubMed ID: 15479722
[TBL] [Abstract][Full Text] [Related]
8. CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis.
Mott PJ; Lazarus AH
PLoS One; 2013; 8(6):e65805. PubMed ID: 23785450
[TBL] [Abstract][Full Text] [Related]
9. Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP.
Leontyev D; Katsman Y; Branch DR
Blood; 2012 May; 119(22):5261-4. PubMed ID: 22508937
[TBL] [Abstract][Full Text] [Related]
10. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects.
Yu X; Menard M; Seabright G; Crispin M; Lazarus AH
Transfusion; 2015 Jun; 55(6 Pt 2):1501-11. PubMed ID: 25752470
[TBL] [Abstract][Full Text] [Related]
12. Antihuman CD44 antibody BJ18 inhibits platelet phagocytosis by correcting aberrant FcɣR expression and M1 polarization in immune thrombocytopenia.
Sun L; Li L; Sun T; Zhang L; Li C; Xu M; Hou Y; Peng J; Hou M; Wang L
Int Immunopharmacol; 2021 Jun; 95():107502. PubMed ID: 33690000
[TBL] [Abstract][Full Text] [Related]
13. GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.
Lewis BJB; Leontyev D; Neschadim A; Blacquiere M; Branch DR
Clin Exp Immunol; 2018 Sep; 193(3):293-301. PubMed ID: 29704458
[TBL] [Abstract][Full Text] [Related]
14. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.
Crow AR; Song S; Freedman J; Helgason CD; Humphries RK; Siminovitch KA; Lazarus AH
Blood; 2003 Jul; 102(2):558-60. PubMed ID: 12649142
[TBL] [Abstract][Full Text] [Related]
15. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies.
Webster ML; Sayeh E; Crow M; Chen P; Nieswandt B; Freedman J; Ni H
Blood; 2006 Aug; 108(3):943-6. PubMed ID: 16861348
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin does not increase FcγRIIB expression levels on monocytes in children with immune thrombocytopenia.
Shimomura M; Hasegawa S; Seki Y; Fukano R; Hotta N; Ichiyama T
Clin Exp Immunol; 2012 Jul; 169(1):33-7. PubMed ID: 22670776
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.
Huang HS; Sun DS; Lien TS; Chang HH
Blood; 2010 Dec; 116(23):5002-9. PubMed ID: 20699442
[TBL] [Abstract][Full Text] [Related]
18. Generation of two high affinity anti-mouse FcRn antibodies: Inhibition of IgG recycling in wild type mice and effect in a mouse model of immune thrombocytopenia.
Smith B; Christodoulou L; Clargo A; Eddleston A; Greenslade K; Lightwood D; Shock A; Tyson K; Brennan FR
Int Immunopharmacol; 2019 Jan; 66():362-365. PubMed ID: 30529500
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.
Crow AR; Lazarus AH
Semin Hematol; 2016 Apr; 53 Suppl 1():S20-2. PubMed ID: 27312158
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia.
Hansen RJ; Balthasar JP
Blood; 2002 Sep; 100(6):2087-93. PubMed ID: 12200371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
